Loading insider details...
Beta
Latest Form 4 (Oct 2, 2026): Grant/Award of 55,924 RNXT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | RenovoRx, Inc. (RNXT) | Grant/Award | 55,924 | n/a |
| Jun 24, 2026 | RenovoRx, Inc. (RNXT) | Other (see footnotes) | 47,789 | $200.2K |
| Oct 3, 2025 | RenovoRx, Inc. (RNXT) | Grant/Award | 47,640 | n/a |
| Jun 6, 2025 | Quince Therapeutics, Inc. (QNCX) | Grant/Award | 27,000 | n/a |
| Oct 2, 2024 | RenovoRx, Inc. (RNXT) | Grant/Award | 25,099 | n/a |
| Jun 8, 2024 | Quince Therapeutics, Inc. (QNCX) | Grant/Award | 27,000 | n/a |
| Oct 2, 2023 | RenovoRx, Inc. (RNXT) | Grant/Award | 25,099 | n/a |
| May 26, 2023 | Quince Therapeutics, Inc. (QNCX) | Grant/Award | 27,000 | n/a |
| Oct 4, 2022 | RenovoRx, Inc. (RNXT) | Grant/Award | 25,099 | n/a |
| Jun 10, 2022 | Cortexyme, Inc. (CRTX) | Grant/Award | 27,000 | n/a |